INHBA and breast cancer: Elucidation of the mechanism of action of INHBA in HER2+ basal breast tumors will also help to devise optimal strategies for potential therapeutic inhibition of INHBA to improve outcomes in patients with advanced basal subtype HER2+ breast cancer.